Antimicrobial peptides (AMPs) are a promising alternative to classical antibiotics in the fight against multi-resistant bacteria. They are produced by organisms from all domains of life and constitute a nearly universal defense mechanism against infectious agents. No drug can be approved without information about its mechanism of action. In order to use them in a clinical setting, it is pivotal to understand how AMPs work. While many pore-forming AMPs are well-characterized in model membrane systems, non-pore-forming peptides are often poorly understood. Moreover, there is evidence that pore formation may not happen or not play a role in vivo. It is therefore imperative to study how AMPs interact with their targets in vivo and consequently kill microorganisms. This has been difficult in the past, since established methods did not provide much mechanistic detail. Especially, methods to study membrane-active compounds have been scarce. Recent advances, in particular in microscopy technology and cell biological labeling techniques, now allow studying mechanisms of AMPs in unprecedented detail. This review gives an overview of available in vivo methods to investigate the antibacterial mechanisms of AMPs. In addition to classical mode of action classification assays, we discuss global profiling techniques, such as genomic and proteomic approaches, as well as bacterial cytological profiling and other cell biological assays. We cover approaches to determine the effects of AMPs on cell morphology, outer membrane, cell wall, and inner membrane properties, cellular macromolecules, and protein targets. We particularly expand on methods to examine cytoplasmic membrane parameters, such as composition, thickness, organization, fluidity, potential, and the functionality of membrane-associated processes. This review aims to provide a guide for researchers, who seek a broad overview of the available methodology to study the mechanisms of AMPs in living bacteria.
Eeyarestatin 24 (ES24) is a promising new antibiotic
with broad-spectrum
activity. It shares structural similarity with nitrofurantoin (NFT),
yet appears to have a distinct and novel mechanism: ES24 was found
to inhibit SecYEG-mediated protein transport and membrane insertion
in Gram-negative bacteria. However, possible additional targets have
not yet been explored. Moreover, its activity was notably better against
Gram-positive bacteria, for which its mechanism of action had not
yet been investigated. We have used transcriptomic stress response
profiling, phenotypic assays, and protein secretion analyses to investigate
the mode of action of ES24 in comparison with NFT using the Gram-positive
model bacterium Bacillus subtilis and have compared
our findings to Gram-negative Escherichia coli. Here,
we show the inhibition of Sec-dependent protein secretion in B. subtilis and additionally provide evidence for DNA damage,
probably caused by the generation of reactive derivatives of ES24.
Interestingly, ES24 caused a gradual dissipation of the membrane potential,
which led to delocalization of cytokinetic proteins and subsequent
cell elongation in E. coli. However, none of those
effects were observed in B. subtilis, thereby suggesting
that ES24 displays distinct mechanistic differences with respect to
Gram-positive and Gram-negative bacteria. Despite its structural similarity
to NFT, ES24 profoundly differed in our phenotypic analysis, which
implies that it does not share the NFT mechanism of generalized macromolecule
and structural damage. Importantly, ES24 outperformed NFT in vivo in a zebrafish embryo pneumococcal infection model.
Our results suggest that ES24 not only inhibits the Sec translocon,
but also targets bacterial DNA and, in Gram-negative bacteria, the
cell membrane.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.